United States Fc Protein and Glycoengineered Antibodies Market Report 2016

United States Fc Protein and Glycoengineered Antibodies Market Report 2016

1 Fc Protein and Glycoengineered Antibodies Overview

1.1 Product Overview and Scope of Fc Protein and Glycoengineered Antibodies

1.2 Classification of Fc Protein and Glycoengineered Antibodies

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Fc Protein and Glycoengineered Antibodies

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Fc Protein and Glycoengineered Antibodies (2011-2021)

1.4.1 United States Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2021)

1.4.2 United States Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2021)

2 United States Fc Protein and Glycoengineered Antibodies Competition by Manufacturers

2.1 United States Fc Protein and Glycoengineered Antibodies Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Fc Protein and Glycoengineered Antibodies Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Fc Protein and Glycoengineered Antibodies Average Price by Manufactures (2015 and 2016)

2.4 Fc Protein and Glycoengineered Antibodies Market Competitive Situation and Trends

2.4.1 Fc Protein and Glycoengineered Antibodies Market Concentration Rate

2.4.2 Fc Protein and Glycoengineered Antibodies Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Fc Protein and Glycoengineered Antibodies Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Fc Protein and Glycoengineered Antibodies Sales and Market Share by Type (2011-2016)

3.2 United States Fc Protein and Glycoengineered Antibodies Revenue and Market Share by Type (2011-2016)

3.3 United States Fc Protein and Glycoengineered Antibodies Price by Type (2011-2016)

3.4 United States Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Type (2011-2016)

4 United States Fc Protein and Glycoengineered Antibodies Sales (Volume) by Application (2011-2016)

4.1 United States Fc Protein and Glycoengineered Antibodies Sales and Market Share by Application (2011-2016)

4.2 United States Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Fc Protein and Glycoengineered Antibodies Manufacturers Profiles/Analysis

5.1 Roche

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Roche Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 TG Therapeutics

5.2.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 TG Therapeutics Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 MedImmune/AstraZeneca

5.3.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 MedImmune/AstraZeneca Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 LFB Biotechnologies

5.4.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 LFB Biotechnologies Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Glycotope

5.5.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Glycotope Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Mentrik Biotech

5.6.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Mentrik Biotech Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 MacroGenics

5.7.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 MacroGenics Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 MorphoSys

5.8.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 MorphoSys Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

6 Fc Protein and Glycoengineered Antibodies Manufacturing Cost Analysis

6.1 Fc Protein and Glycoengineered Antibodies Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Fc Protein and Glycoengineered Antibodies

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Fc Protein and Glycoengineered Antibodies Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Fc Protein and Glycoengineered Antibodies Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Fc Protein and Glycoengineered Antibodies Market Forecast (2016-2021)

10.1 United States Fc Protein and Glycoengineered Antibodies Sales, Revenue Forecast (2016-2021)

10.2 United States Fc Protein and Glycoengineered Antibodies Sales Forecast by Type (2016-2021)

10.3 United States Fc Protein and Glycoengineered Antibodies Sales Forecast by Application (2016-2021)

10.4 Fc Protein and Glycoengineered Antibodies Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Fc Protein and Glycoengineered Antibodies

Table Classification of Fc Protein and Glycoengineered Antibodies

Figure United States Sales Market Share of Fc Protein and Glycoengineered Antibodies by Type in 2015

Table Application of Fc Protein and Glycoengineered Antibodies

Figure United States Sales Market Share of Fc Protein and Glycoengineered Antibodies by Application in 2015

Figure United States Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2011-2021)

Figure United States Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2011-2021)

Table United States Fc Protein and Glycoengineered Antibodies Sales of Key Manufacturers (2015 and 2016)

Table United States Fc Protein and Glycoengineered Antibodies Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Fc Protein and Glycoengineered Antibodies Sales Share by Manufacturers

Figure 2016 Fc Protein and Glycoengineered Antibodies Sales Share by Manufacturers

Table United States Fc Protein and Glycoengineered Antibodies Revenue by Manufacturers (2015 and 2016)

Table United States Fc Protein and Glycoengineered Antibodies Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Fc Protein and Glycoengineered Antibodies Revenue Share by Manufacturers

Table 2016 United States Fc Protein and Glycoengineered Antibodies Revenue Share by Manufacturers

Table United States Market Fc Protein and Glycoengineered Antibodies Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Fc Protein and Glycoengineered Antibodies Average Price of Key Manufacturers in 2015

Figure Fc Protein and Glycoengineered Antibodies Market Share of Top 3 Manufacturers

Figure Fc Protein and Glycoengineered Antibodies Market Share of Top 5 Manufacturers

Table United States Fc Protein and Glycoengineered Antibodies Sales by Type (2011-2016)

Table United States Fc Protein and Glycoengineered Antibodies Sales Share by Type (2011-2016)

Figure United States Fc Protein and Glycoengineered Antibodies Sales Market Share by Type in 2015

Table United States Fc Protein and Glycoengineered Antibodies Revenue and Market Share by Type (2011-2016)

Table United States Fc Protein and Glycoengineered Antibodies Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Fc Protein and Glycoengineered Antibodies by Type (2011-2016)

Table United States Fc Protein and Glycoengineered Antibodies Price by Type (2011-2016)

Figure United States Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Type (2011-2016)

Table United States Fc Protein and Glycoengineered Antibodies Sales by Application (2011-2016)

Table United States Fc Protein and Glycoengineered Antibodies Sales Market Share by Application (2011-2016)

Figure United States Fc Protein and Glycoengineered Antibodies Sales Market Share by Application in 2015

Table United States Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Application (2011-2016)

Figure United States Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Application (2011-2016)

Table Roche Basic Information List

Table Roche Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Roche Fc Protein and Glycoengineered Antibodies Sales Market Share (2011-2016)

Table TG Therapeutics Basic Information List

Table TG Therapeutics Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table TG Therapeutics Fc Protein and Glycoengineered Antibodies Sales Market Share (2011-2016)

Table MedImmune/AstraZeneca Basic Information List

Table MedImmune/AstraZeneca Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table MedImmune/AstraZeneca Fc Protein and Glycoengineered Antibodies Sales Market Share (2011-2016)

Table LFB Biotechnologies Basic Information List

Table LFB Biotechnologies Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table LFB Biotechnologies Fc Protein and Glycoengineered Antibodies Sales Market Share (2011-2016)

Table Glycotope Basic Information List

Table Glycotope Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table Glycotope Fc Protein and Glycoengineered Antibodies Sales Market Share (2011-2016)

Table Mentrik Biotech Basic Information List

Table Mentrik Biotech Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mentrik Biotech Fc Protein and Glycoengineered Antibodies Sales Market Share (2011-2016)

Table MacroGenics Basic Information List

Table MacroGenics Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table MacroGenics Fc Protein and Glycoengineered Antibodies Sales Market Share (2011-2016)

Table MorphoSys Basic Information List

Table MorphoSys Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table MorphoSys Fc Protein and Glycoengineered Antibodies Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Fc Protein and Glycoengineered Antibodies

Figure Manufacturing Process Analysis of Fc Protein and Glycoengineered Antibodies

Figure Fc Protein and Glycoengineered Antibodies Industrial Chain Analysis

Table Raw Materials Sources of Fc Protein and Glycoengineered Antibodies Major Manufacturers in 2015

Table Major Buyers of Fc Protein and Glycoengineered Antibodies

Table Distributors/Traders List

Figure United States Fc Protein and Glycoengineered Antibodies Production and Growth Rate Forecast (2016-2021)

Figure United States Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate Forecast (2016-2021)

Table United States Fc Protein and Glycoengineered Antibodies Production Forecast by Type (2016-2021)

Table United States Fc Protein and Glycoengineered Antibodies Consumption Forecast by Application (2016-2021)